FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma
MONDAY, Nov. 19, 2018 -- The U.S. Food and Drug Administration on Friday expanded approval for the use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with specific types of peripheral T-cell lymphoma...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Chemotherapy | Food and Drug Administration (FDA) | Lymphoma | Pharmaceuticals | T-cell Lymphoma